Suppr超能文献

佛罗里达州迈阿密服务不足的少数族裔社区中的药物使用与 COVID-19 检测、疫苗接种和感染情况。

Drug use and COVID-19 testing, vaccination, and infection among underserved, minority communities in Miami, Florida.

机构信息

Robert Stempel College of Public Health & Social Work, Florida International University, Miami, Florida, United States of America.

Faculty of Medicine, University of Colima, Las Víboras, Colima, Mexico.

出版信息

PLoS One. 2024 Apr 30;19(4):e0297327. doi: 10.1371/journal.pone.0297327. eCollection 2024.

Abstract

The Coronavirus Disease 2019 (COVID-19) pandemic has disproportionately impacted people who use drugs (PWUD). This study explored relationships between drug use, COVID-19 testing, vaccination, and infection. This cross-sectional study was conducted in Miami, Florida between March 2021 and October 2022 as part of the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) initiative and the Miami Adult Studies on HIV (MASH) cohort. Users of cannabis, cocaine/crack, heroin/fentanyl, methamphetamines, hallucinogens, and/or prescription drug misuse in the previous 12 months were considered PWUD. Sociodemographic data, COVID-19 testing history, and vaccination-related beliefs were self-reported. Vaccinations were confirmed with medical records and positivity was determined with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing. Statistical analyses included chi-square tests and logistic regression. Of 1,780 participants, median age was 57 years, 50.7% were male, 50.2% Non-Hispanic Black, and 66.0% reported an annual income less than $15,000. Nearly 28.0% used drugs. PWUD were less likely than non-users to self-report ever testing positive for SARS-CoV-2 (14.7% vs. 21.0%, p = 0.006). However, 2.6% of participants tested positive for SARS-CoV-2, with no significant differences between PWUD and non-users (3.7% vs. 2.2%, p = 0.076). PWUD were more likely than non-users to experience difficulties accessing testing (10.2% vs. 7.1%, p = 0.033), vaccine hesitancy (58.9% vs. 43.4%, p = 0.002) and had lower odds of receiving any dose of a COVID-19 vaccine compared to non-users (aOR, 0.63; 95% CI, 0.49-0.81; p<0.001). PWUD presented with greater difficulties accessing COVID-19 testing, greater vaccine hesitancy, and lower odds of vaccination. Testing and immunization plans that are tailored to the needs of PWUD and consider access, trust-building campaigns, and education may be needed.

摘要

2019 年冠状病毒病(COVID-19)大流行对吸毒者(PWUD)造成了不成比例的影响。本研究探讨了吸毒、COVID-19 检测、疫苗接种和感染之间的关系。这项横断面研究于 2021 年 3 月至 2022 年 10 月在佛罗里达州迈阿密进行,作为美国国立卫生研究院(NIH)加速诊断弱势人群(RADx-UP)计划和迈阿密成人 HIV 研究(MASH)队列的一部分。在过去 12 个月内使用大麻、可卡因/快克、海洛因/芬太尼、冰毒、致幻剂和/或处方药物滥用的人被视为 PWUD。社会人口统计学数据、COVID-19 检测史和疫苗接种相关信念均为自我报告。疫苗接种情况通过医疗记录确认,通过严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)检测确定阳性。统计分析包括卡方检验和逻辑回归。在 1780 名参与者中,中位年龄为 57 岁,50.7%为男性,50.2%为非西班牙裔黑人,66.0%报告年收入低于 15000 美元。近 28.0%的人使用毒品。与非使用者相比,PWUD 自我报告 SARS-CoV-2 检测呈阳性的可能性较低(14.7%比 21.0%,p=0.006)。然而,有 2.6%的参与者 SARS-CoV-2 检测呈阳性,PWUD 和非使用者之间没有显著差异(3.7%比 2.2%,p=0.076)。与非使用者相比,PWUD 更有可能难以接受检测(10.2%比 7.1%,p=0.033)、对疫苗犹豫不决(58.9%比 43.4%,p=0.002),并且与非使用者相比,接受任何剂量 COVID-19 疫苗的可能性较低(aOR,0.63;95%CI,0.49-0.81;p<0.001)。PWUD 在获得 COVID-19 检测、疫苗犹豫方面面临更大的困难,以及接种疫苗的可能性较低。可能需要针对 PWUD 的需求制定测试和免疫计划,并考虑获取途径、建立信任的宣传活动和教育。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae1/11060546/830e03b14e8d/pone.0297327.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验